MXPA01009467A - Metodo para controlar el aumento de peso asociado con farmacos terapeuticos. - Google Patents

Metodo para controlar el aumento de peso asociado con farmacos terapeuticos.

Info

Publication number
MXPA01009467A
MXPA01009467A MXPA01009467A MXPA01009467A MXPA01009467A MX PA01009467 A MXPA01009467 A MX PA01009467A MX PA01009467 A MXPA01009467 A MX PA01009467A MX PA01009467 A MXPA01009467 A MX PA01009467A MX PA01009467 A MXPA01009467 A MX PA01009467A
Authority
MX
Mexico
Prior art keywords
weight gain
gain associated
therapeutic drugs
controlling weight
certain
Prior art date
Application number
MXPA01009467A
Other languages
English (en)
Inventor
Carl M Mendel
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of MXPA01009467A publication Critical patent/MXPA01009467A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se usa un compuesto de la formula (I): (ver formula) o una sal farmaceuticarnente aceptable del mismo, donde R1, y R2 son independientemente H o metilo (por ejemplo, clorhidrato de N,N-dimetil-1-[1-(4-clorofenil)ciclobutil]-3-rnetilbutilamina, opcionalmente en la forma de su monohidrato), para tratar el aumento de peso asociado con el tratamiento con cierta terapia de farmacos, incluyendo el uso de antidepresivos triciclicos, litio, sulfonilureas, bloqueadores beta-adrenergicos, ciertos anticonceptivos esteroidales, insulina, ciproheptadina, valproato de sodio, neurolepticos, fenotiazina o piztifen.
MXPA01009467A 1999-03-19 2000-03-17 Metodo para controlar el aumento de peso asociado con farmacos terapeuticos. MXPA01009467A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12534099P 1999-03-19 1999-03-19
PCT/US2000/007130 WO2000056313A1 (en) 1999-03-19 2000-03-17 Method of controlling weight gain associated with therapeutic drugs

Publications (1)

Publication Number Publication Date
MXPA01009467A true MXPA01009467A (es) 2004-03-19

Family

ID=22419292

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01009467A MXPA01009467A (es) 1999-03-19 2000-03-17 Metodo para controlar el aumento de peso asociado con farmacos terapeuticos.

Country Status (20)

Country Link
US (1) US6376552B1 (es)
EP (1) EP1162965A1 (es)
JP (1) JP2002539251A (es)
KR (1) KR20020000784A (es)
CN (1) CN1353603A (es)
AU (1) AU3757800A (es)
BG (1) BG105997A (es)
BR (1) BR0009159A (es)
CA (1) CA2367021A1 (es)
CZ (1) CZ291864B6 (es)
HU (1) HUP0200393A2 (es)
IL (1) IL145241A0 (es)
MX (1) MXPA01009467A (es)
NO (1) NO20014480L (es)
NZ (1) NZ514009A (es)
PL (1) PL350919A1 (es)
SK (1) SK13352001A3 (es)
TR (1) TR200102695T2 (es)
WO (1) WO2000056313A1 (es)
ZA (1) ZA200107692B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002019998A2 (en) * 2000-09-08 2002-03-14 Eli Lilly And Company A method of treating weight gain associated with atypical antipsychotic use
RU2290924C2 (ru) * 2002-10-05 2007-01-10 Ханми Фарм. Ко., Лтд. Фармацевтическая композиция, включающая кристаллический полугидрат метансульфоната сибутрамина
US20050131074A1 (en) * 2003-08-04 2005-06-16 Beckman Kristen M. Methods for treating metabolic syndrome
US20060035827A1 (en) * 2004-06-24 2006-02-16 Green Gary M Compositions and methods for the treatment or prevention of gallbladder disease
KR20060080818A (ko) 2005-01-06 2006-07-11 씨제이 주식회사 시부트라민의 술폰산염
KR20060080817A (ko) 2005-01-06 2006-07-11 씨제이 주식회사 시부트라민의 디카복실산염
EP1846359A4 (en) * 2005-01-06 2010-03-31 Cj Cheiljedang Corp INORGANIC ACID SALTS OF SIBUTRAMINE
KR20060093564A (ko) * 2005-02-22 2006-08-25 종근당바이오 주식회사 무수 시부트라민 말산염 및 이의 제조 방법
KR100627687B1 (ko) * 2005-04-20 2006-09-25 주식회사 씨티씨바이오 시부트라민 유리염기 함유 조성물 및 이의 제조방법
US7989500B2 (en) * 2006-09-15 2011-08-02 Reviva Pharmaceuticals, Inc. Synthesis, methods of using, and compositions of cycloalkylmethylamines
EP2083867A1 (en) * 2006-11-22 2009-08-05 SK Chemicals, Co., Ltd. Inclusion complex of sibutramine and beta-cyclodextrin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2675573B2 (ja) * 1988-03-31 1997-11-12 科研製薬株式会社 脳機能改善剤
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
US5459164A (en) 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment

Also Published As

Publication number Publication date
TR200102695T2 (tr) 2002-01-21
BR0009159A (pt) 2001-12-26
NO20014480D0 (no) 2001-09-14
EP1162965A1 (en) 2001-12-19
NZ514009A (en) 2001-09-28
JP2002539251A (ja) 2002-11-19
CN1353603A (zh) 2002-06-12
CA2367021A1 (en) 2000-09-28
SK13352001A3 (sk) 2002-03-05
BG105997A (en) 2002-06-28
CZ291864B6 (cs) 2003-06-18
HUP0200393A2 (en) 2002-08-28
ZA200107692B (en) 2002-12-18
AU3757800A (en) 2000-10-09
IL145241A0 (en) 2002-06-30
WO2000056313A1 (en) 2000-09-28
KR20020000784A (ko) 2002-01-05
PL350919A1 (en) 2003-02-10
CZ20013283A3 (cs) 2002-07-17
US6376552B1 (en) 2002-04-23
NO20014480L (no) 2001-11-02

Similar Documents

Publication Publication Date Title
MXPA01009467A (es) Metodo para controlar el aumento de peso asociado con farmacos terapeuticos.
NO20053104L (no) Oral, analgesisk doseringsform med forlenget frigivelse for administrering ±n gang pr. dag.
IT1271495B (it) Composizione farmaceutica contenente 3-2 (dimetilammino) etil-n-metil-1h-indol-5-metansolfonammide, relativo procedimento di preparazione e impiego della stessa nel trattamento di mammiferi
RU2003135482A (ru) Геропротектор на основе гидрированных пиридо(4,3-b) индолов (варианты), фармакологическое средство на его основе и способ его применения
US20100093754A1 (en) Pharmaceutical Compositions Comprising Flibanserin and a Further Agent in the Treatment of Sexual Disorders
RU2004135563A (ru) Лекарственное средство для лечения повышенной активности мочевого пузыря
JP4377585B2 (ja) 射精遅延の方法
IL177626A0 (en) Pharmaceutical compositions for treating sleep apnoea
HU229502B1 (en) Use of epinastine in the treatment of allergic rithinis/conjuctivitis
AU4385197A (en) Medical treatment
JP2021502392A5 (es)
WO2000056315A8 (en) Treatment of pain
ZA922910B (en) Heterocylic pharmaceutical compounds preparation and use
RU2005135649A (ru) Комбинации пароксетина и 4-(s)-(4-ацетилпиперазин-1-ил)-2-(r)-(4-фтор-2-метилфенил)пиперидин-1-карбоновой кислоты [1-(r)-(3, 5-бис-трифторметилфенил)этил]метиламида для лечения депрессии и/или тревоги
BG106180A (en) Pharmaceutical composition containing sibutramine and orlistat
JPH08188531A (ja) ビシクロヘプタン誘導体を含む製剤組成物、その製造法、ならびにコレシストキニン系に対する影響に関連する障害の治療のためのその用途
MY133438A (en) Morpholinobenzamide salts
BG106209A (en) Therapeutic agents
MXPA01009468A (es) Tratamiento de hipertension pulmonar.
JP4360292B2 (ja) 疼痛閾値低下抑制剤
WO1996011678A1 (en) Method for attenuation of sympathetic nervous system activity or onset of migraine by selectively metabolized beta-blocking agents
MXPA01009463A (es) Tratamiento de hernia hiatial.
MXPA01009462A (es) Tratamiento de calculos biliares.
RU2002102075A (ru) Терапевтические агенты
DE60026559D1 (de) Arzneimittel gegen essstörungen